Lite Strategy, Inc. (LITS) shareholders
Close on Nov 17, 2026Market cap $24.17MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of LITS | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 1,247,350 | 4.10% | $1.15M | −497,350 | 0.00% |
| Vanguard Capital Management LLC | 1,021,892 | 3.36% | $942.18K | −21,421 | 0.00% |
| RLH Capital LLC | 806,433 | 2.65% | $743.85K | New | 0.36% |
| Two Sigma Investments, LP | 557,011 | 1.83% | $513.79K | −57,431 | 0.00% |
| Geode Capital Management, LLC | 365,019 | 1.20% | $337.09K | −36,072 | 0.00% |
| Citadel Advisors LLC | 357,529 | 1.18% | $329.79K | −372,570 | 0.00% |
| BlackRock, Inc. | 275,829 | 0.91% | $254.43K | +117,938 | 0.00% |
| Marshall Wace, Llp | 232,979 | 0.77% | $214.34K | −100,529 | 0.00% |
| Vanguard Fiduciary Trust Co | 195,392 | 0.64% | $180.15K | +1,397 | 0.00% |
| Jane Street Group, LLC | 192,627 | 0.63% | $177.68K | +135,381 | 0.00% |
| State Street Corp | 115,021 | 0.38% | $106.10K | – | 0.00% |
| UBS Group AG | 91,141 | 0.30% | $84.03K | +39,791 | 0.00% |
| Northern Trust Corp | 75,497 | 0.25% | $69.64K | −4,734 | 0.00% |
| Morgan Stanley | 71,408 | 0.23% | $65.87K | +50 | 0.00% |
| XTX Topco Ltd | 68,165 | 0.22% | $62.88K | −67,859 | 0.00% |
| ADAR1 Capital Management, LLC | 67,292 | 0.22% | $62.07K | – | 0.00% |
| Gsa Capital Partners Llp | 61,850 | 0.20% | $57.00K | New | 0.00% |
| Nomura Asset Management International Inc. | 29,999 | 0.10% | $28.00K | – | 0.00% |
| Vanguard Global Advisers, LLC | 17,937 | 0.06% | $16.54K | – | 0.00% |
| Susquehanna International Group, Llp | 15,821 | 0.05% | $14.59K | −313 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 35 | 6M | 19.4% | 4 / 5 | 11 / 4 | 1M | 1M |
| Q1 2026 | 36 | 6M | 19.4% | 9 / 3 | 8 / 13 | 2M | 3M |
| Q4 2025 | 41 | 8M | 27.2% | 9 / 11 | 11 / 15 | 3M | 5M |
| Q3 2025 | 47 | 10M | 33.4% | 24 / 12 | 2 / 8 | 9M | 2M |
| Q2 2025 | 31 | 3M | 8.6% | 4 / 5 | 6 / 4 | 0M | 0M |
| Q1 2025 | 31 | 3M | 8.8% | 1 / 6 | 9 / 2 | 0M | 0M |
| Q4 2024 | 32 | 3M | 8.9% | 8 / 4 | 8 / 6 | 0M | 0M |
| Q3 2024 | 30 | 3M | 9.0% | 6 / 6 | 9 / 7 | 0M | 0M |
| Q2 2024 | 32 | 3M | 9.0% | 2 / 7 | 12 / 2 | 0M | 0M |
| Q1 2024 | 32 | 3M | 9.5% | 3 / 8 | 8 / 2 | 0M | 0M |
| Q4 2023 | 31 | 3M | 10.4% | 4 / 10 | 10 / 2 | 1M | 0M |
| Q3 2023 | 29 | 3M | 8.3% | 3 / 9 | 6 / 3 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
10 funds held LITS in Q2 2026, 76% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of LITS | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 659,936 | 2.17% | $608.72K | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 361,956 | 1.19% | $333.87K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 204,707 | 0.67% | $206.75K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 110,588 | 0.36% | $102.01K | 0.01% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 54,468 | 0.18% | $55.01K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 49,681 | 0.16% | $50.18K | 0.00% | May 31, 2026 |
| Nomura Healthcare Fund | 30,000 | 0.10% | $27.67K | 0.00% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 15,724 | 0.05% | $15.88K | 0.00% | May 31, 2026 |
| 1290 VT Micro Cap Portfolio | 7,350 | 0.02% | $6.78K | 0.00% | Jun 30, 2026 |
| Blackstone Alternative Multi-Strategy Fund | 1,900 | 0.01% | $1.75K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Justin J. File | CEO, CFO and Secretary, Director | – | – | Oct 26, 2026 |
| Nicholas Glover | Director | 2,000 | 0.01% | Oct 26, 2026 |
| Frederick W. Driscoll | Director | 1,875 | 0.01% | Oct 26, 2026 |
| James P. Flynn | Director | 125,000 | 0.41% | Oct 26, 2026 |
| Joshua Riezman | Director | – | – | Oct 26, 2026 |
| Charles Benjamin Lee | Director | 292,397 | 0.96% | Oct 6, 2025 |
| Steven D. Wood | Director | 72,092 | 0.24% | Jul 17, 2025 |
| Thomas C. Reynolds | Director | 500 | 0.00% | Jul 17, 2025 |
| Alexander Schornstein | 10% owner | 3,674,862 | 12.09% | Dec 22, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| James P. Flynn Director | Jun 24, 2026 | Buy | +25,000 | $0.86 | $21.50K | 125,000 |
| James P. Flynn Director | Dec 19, 2025 | Buy | +70,000 | $1.40 | $98.00K | 100,000 |
| Alexander Schornstein 10% owner | Dec 18, 2025 | Sale | −690,611 | $1.37 | $946.14K | 3,674,862 |
| James P. Flynn Director | Nov 19, 2025 | Buy | +12,100 | $1.88 | $22.75K | 30,000 |
| James P. Flynn Director | Sep 30, 2025 | Award | +10,000 | $2.54 | $25.40K | 17,900 |
| Nicholas Glover Director | Jul 23, 2025 | Buy | +1,000 | $6.00 | $6.00K | 2,000 |
| Nicholas Glover Director | Jul 22, 2025 | Buy | +1,000 | $6.55 | $6.55K | 1,000 |
| Steven D. Wood Director | May 17, 2024 | Award | +3,100 | $3.17 | $9.83K | 4,359 |
| James P. Flynn Director | May 16, 2024 | Award | +7,900 | $3.16 | $24.96K | 7,900 |
| Funicular Funds, LP 10% owner | Oct 20, 2023 | Option exercise | +120,600 | $7.00 | $844.20K | 611,440 |
| Moez Kassam 10% owner | Oct 20, 2023 | Option exercise | +143,200 | $7.00 | $1.00M | 1,057,388 |
| Moez Kassam 10% owner | Oct 20, 2023 | Option exercise | +35,800 | $7.00 | $250.60K | 1,093,188 |
| Funds Management LP Anson 10% owner | Oct 11, 2023 | Option exercise | +10,000 | $7.00 | $70.00K | 914,188 |
| Funds Management LP Anson 10% owner | Oct 11, 2023 | Option exercise | +40,000 | $7.00 | $280.00K | 904,188 |
| Jacob Ma-Weaver 10% owner | Oct 11, 2023 | Option exercise | +30,000 | $7.00 | $210.00K | 490,840 |
| Bruce Ross Winson 10% owner | Sep 22, 2023 | Buy | +48,060 | $6.85 | $329.21K | 864,188 |
| Jacob Ma-Weaver 10% owner | Sep 22, 2023 | Buy | +32,040 | $6.85 | $219.47K | 460,840 |
| Jacob Ma-Weaver 10% owner | Sep 21, 2023 | Buy | +22,400 | $6.46 | $144.70K | 428,800 |
| Moez Kassam 10% owner | Sep 21, 2023 | Buy | +33,600 | $6.46 | $217.06K | 816,128 |
| Jacob Ma-Weaver 10% owner | Sep 20, 2023 | Buy | +80,000 | $6.01 | $480.80K | 406,400 |
| Moez Kassam 10% owner | Sep 20, 2023 | Buy | +120,000 | $6.01 | $721.20K | 782,528 |
| Charles V. Baltic III Director | Feb 28, 2023 | Buy | +81,500 | $0.23 | $18.75K | 105,750 |
| Richard G. Ghalie Chief Medical Officer | Jul 5, 2022 | Tax withholding | −8,196 | $0.54 | $4.43K | 28,927 |
| David M. Urso Chief Operating Officer & GC | Jul 2, 2021 | Tax withholding | −24,825 | $2.94 | $72.99K | 49,281 |
| Daniel P. Gold Phd Chief Executive Officer, Director | Jul 2, 2021 | Tax withholding | −41,320 | $2.94 | $121.48K | 417,312 |
| Daniel P. Gold Phd Chief Executive Officer, Director | May 25, 2021 | Option exercise | +5,000 | $2.52 | $12.60K | 458,632 |
| Frederick W. Driscoll Director | Feb 23, 2021 | Sale | −25,000 | $4.03 | $100.75K | 37,500 |
| Daniel P. Gold Phd Chief Executive Officer, Director | Jul 23, 2020 | Option exercise | +12,000 | $1.57 | $18.84K | 453,632 |
| David M. Urso Chief Operating Officer & GC | Jul 2, 2020 | Award | +50,000 | – | – | 74,106 |
| Daniel P. Gold Phd Chief Executive Officer, Director | Jul 2, 2020 | Award | +80,000 | – | – | 441,632 |
| Daniel P. Gold Phd Chief Executive Officer, Director | Dec 19, 2019 | Buy | +18,750 | $1.60 | $30.00K | 361,632 |
| Thomas C. Reynolds Director | Dec 19, 2019 | Buy | +10,000 | $1.60 | $16.00K | 10,000 |
| Frederick W. Driscoll Director | Dec 19, 2019 | Buy | +62,500 | $1.60 | $100.00K | 62,500 |
| Brian G. Drazba Chief Financial Officer | Dec 19, 2019 | Buy | +12,500 | $1.60 | $20.00K | 37,500 |
| Daniel P. Gold Phd Chief Executive Officer, Director | Sep 27, 2019 | Option exercise | +20,000 | $1.57 | $31.40K | 342,882 |
| Christine Anna White Director | Sep 6, 2019 | Buy | +15,000 | $1.74 | $26.10K | 15,000 |
| David M. Urso Chief Operating Officer & GC | Aug 7, 2018 | Sale | −9,500 | $3.58 | $34.01K | 24,106 |
| Daniel P. Gold Phd Chief Executive Officer, Director | Aug 6, 2018 | Tax withholding | −50,938 | $3.75 | $191.02K | 322,882 |
| Robert D. Mass Chief Medical Officer | Aug 6, 2018 | Tax withholding | −17,709 | $3.75 | $66.41K | 33,661 |
| Daniel P. Gold Phd Chief Executive Officer, Director | Aug 6, 2018 | Tax withholding | −54,093 | $3.75 | $202.85K | 319,727 |
| David M. Urso Chief Operating Officer & GC | Aug 6, 2018 | Tax withholding | −17,764 | $3.75 | $66.62K | 33,606 |
| Daniel P. Gold Phd Chief Executive Officer, Director | Mar 29, 2018 | Tax withholding | −128,920 | $2.07 | $266.86K | 271,080 |
| Charles V. Baltic III Director | Nov 27, 2017 | Sale | −11,000 | $2.21 | $24.31K | 13,250 |
| Charles V. Baltic III Director | Nov 27, 2017 | Buy | +11,000 | $2.25 | $24.75K | 24,250 |
| Vivo Ventures Vii, Llc 10% owner | Nov 9, 2015 | Sale | −157,352 | $1.75 | $275.37K | 3,163,105 |
| Vivo Ventures V, LLC 10% owner | Nov 9, 2015 | Sale | −9,142 | $1.75 | $16.00K | 183,767 |
| Vivo Ventures Vii, Llc 10% owner | Nov 6, 2015 | Sale | −7,560 | $1.85 | $13.99K | 3,320,457 |
| Vivo Ventures V, LLC 10% owner | Nov 6, 2015 | Sale | −440 | $1.85 | $814 | 192,909 |
| Vivo Ventures Vii, Llc 10% owner | Nov 5, 2015 | Sale | −225,660 | $1.91 | $431.01K | 3,328,017 |
| Vivo Ventures V, LLC 10% owner | Nov 5, 2015 | Sale | −13,111 | $1.91 | $25.04K | 193,349 |
| Vivo Ventures Vii, Llc 10% owner | Mar 24, 2015 | Exercise | +455,174 | $3.12 | $1.42M | 3,553,677 |
| Vivo Ventures V, LLC 10% owner | Mar 24, 2015 | Exercise | +26,445 | $3.12 | $82.51K | 206,460 |
| Jeani Delagardelle 10% owner | Mar 24, 2015 | Sale | −1,601,390 | $1.97 | $3.15M | 0 |
| Charles V. Baltic III Director | Jan 21, 2015 | Buy | +5,000 | $3.81 | $19.05K | 24,250 |
| Charles V. Baltic III Director | Dec 31, 2014 | Buy | +1,500 | $4.26 | $6.39K | 5,350 |
| Charles V. Baltic III Director | Dec 31, 2014 | Buy | +1,500 | $4.28 | $6.42K | 19,250 |
| Ronald Hunt 10% owner | Dec 9, 2014 | Sale | −70,081 | $6.01 | $421.19K | 1,601,390 |
| Ronald Hunt 10% owner | Dec 8, 2014 | Sale | −9,004 | $6.05 | $54.47K | 1,671,471 |
| Charles V. Baltic III Director | Jun 30, 2014 | Buy | +950 | $6.60 | $6.27K | 3,850 |
| Charles V. Baltic III Director | Jun 30, 2014 | Buy | +1,050 | $6.52 | $6.85K | 17,750 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Lite Strategy's stock actually held short. Settlement fails (shares not delivered on time) peaked at 46,763 shares on Oct 5, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Anson Funds Management LP Former 10% Stockholder | Jul 28, 2025 | 1,093,184 | $7.37M | Jul 28, 2025 | Open Market Purchase(1) |
| Funicular Funds, LP Former member of group that owned 10% | Jul 23, 2025 | 611,440 | $3.79M | Jul 23, 2025 | Open Market Purchase(1) |
| Baltic Charles V. III Director | Jul 22, 2024 | 5,000 | $17.06K | Jul 22, 2024 | Open Market Purchase |
See a number that looks wrong?